Do Not Offer Bamlanivimab Monotherapy At This Time
Based on HHS and FDA recommendations, Bamlanivimab monotherapy should NOT be offered for COVID positive patients with mild to moderate disease. Due to variants, combination therapy of bamlanivimab and etesevimab should be offered. For now, St. Joseph’s will not offer Bamlanivimab monotherapy until we are able to obtain etesevimab.
Do Not Offer Bamlanivimab Monotherapy At This Time Read More »